Genome-Wide Identification and Validation of Gene Expression Biomarkers in the Diagnosis of Ovarian Serous Cystadenocarcinoma

Genome-Wide Identification and Validation of Gene Expression Biomarkers in the Diagnosis of Ovarian Serous Cystadenocarcinoma

Ovarian cancer is the second most prevalent gynecologic malignancy, and ovarian serous cystadenocarcinoma (OSCA) is the most common and lethal subtype of ovarian cancer. Current screening methods have strong limits on early detection, and the majority of OSCA patients relapse. In this work, we devel...

Full description

Bibliographic Details
Main Authors: Francesca Zalfa, Maria Grazia Perrone, Savina Ferorelli, Luna Laera, Ciro Leonardo Pierri, Anna Tolomeo, Vincenzo Dimiccoli, Giuseppe Perrone, Anna De Grassi, Antonio Scilimati
Format: Article
Language:English
Published: MDPI AG 2022-08-01
Series:Cancers
Subjects:
ovarian serous cystadenocarcinoma (OSCA)
biomarkers
TCGA transcriptomes
digital RNA detection
NanoString technology
Online Access:https://www.mdpi.com/2072-6694/14/15/3764

Similar Items

Similar Items